MCR

Protect Your Heart Before Heart Failure Starts

If you’re living with Type 2 Diabetes, High Blood Pressure, and Heart Disease, you may qualify for a clinical research study evaluating a potential new way to help reduce the risk of developing heart failure before symptoms begin.

Heart Failure Prevention Study Pre-Screening

Complete this short form to see if you may qualify for this cardiovascular clinical research study.

Study Pre-Screening

Takes 5-10 minutes to complete. Your information is confidential.

Privacy Notice: This does not enroll you in a study. It helps us determine if you may qualify. Your information is kept private and used only to contact you about research opportunities for which you may be eligible.

🔒 Your information is securely handled and not shared outside the research team.

participation requirements

Who We're Looking For

eligibility criteria

Adults meeting the following conditions may qualify

Are 40 years or older

Have Type 2 Diabetes

Have High Blood Pressure

Have Heart Disease or Cardiovascular Disease

Have not been diagnosed with symptomatic heart failure

study benefit

Why Participate?

Study-Related Care

Receive study-related evaluations and care at no cost.

Heart Health Monitoring

Regular monitoring of your heart health throughout the study.

Experienced Research Team

Receive care from an experienced cardiovascular research team.

Help Advance Medical Research

Your participation may help improve future approaches to preventing heart failure.

ELIGIBILITY CRITERIA

Are You at Increased Risk for Heart Failure? 

Answer a few quick questions to see if this study may be right for you.

You May Qualify If:

You May Not Qualify If:

Note: Completing the pre-screening form does not guarantee eligibility. Our research team will review your information and contact you to discuss the next steps.

About the Heart Failure Prevention Study

Researchers are evaluating an investigational medication in combination with an approved medication to determine whether it may help reduce the risk of developing heart failure in adults at increased cardiovascular risk.

The study is designed for adults living with Type 2 Diabetes, High Blood Pressure, and Heart Disease who have not yet developed symptomatic heart failure.

By participating, you could help researchers advance future approaches to heart failure prevention.

Understanding Heart Failure
What Is Heart Failure?

Heart failure does not mean your heart has stopped working. It means the heart cannot pump blood as effectively as it should.Many people are at increased risk long before symptoms appear.
Conditions such as:

  • Type 2 Diabetes
  • High Blood Pressure
  • Heart Disease

can significantly increase the likelihood of developing heart failure over time.Early research is focused on finding better ways to help reduce this risk before symptoms begin.

 

About Dr. Ayim Djamson

Dr. Ayim Djamson is a board-certified cardiologist with more than 20 years of clinical research experience. He has served as Principal Investigator on over 50 Phase II–IV clinical trials, helping advance new treatments for heart-related conditions.

Board-Certified Cardiologist

Dr. Ayim Djamson
MD, FACC

Cardiovascular Research

Leading heart health clinical trials

Patient-Centered Care

Dedicated to safe, compassionate research

At Metropolitan Cardiovascular Research, Dr. Djamson is committed to providing compassionate, patient-centered care while helping shape the future of cardiovascular medicine through clinical research.

What to Expect

Step 1

Complete the online pre-screening form.

Step 2

Speak with a member of our research team.

Step 3

Schedule a screening visit if you appear eligible.

Step 4

The study team will determine whether you qualify for enrollment.

Take the First Step Today

Call (240) 685-2078 or email info@metresearch.org to speak with our research team and learn if you may qualify for this study. 

Address

10756 Rhode Island
Avenue Beltsville, MD
20705

Hours

Monday – Friday: 9:00 AM – 5:30 PM
Saturday – Sunday: Closed

Transportation

Ready to Get Started? Started?

Complete our short eligibility questionnaire or contact our research team to learn more
about this clinical research study.

Frequently Asked Questions

Why is this study being conducted?

Researchers are studying whether an investigational treatment, used alongside an approved medication, may help reduce the risk of heart failure in adults who are at increased cardiovascular risk.

People with Type 2 Diabetes, High Blood Pressure, and Heart Disease have a greater chance of developing heart failure over time.

An investigational medication is a treatment that is being studied to determine its safety and effectiveness. It has not yet been approved for this specific use.

The study team will review your current medications and explain how the study treatment fits into your care before you decide whether to participate.